Cost-cutting and other restructuring measures at Galaxy Nutritional
Foods, the producer of nutritious plant-based dairy alternatives,
are beginning to have a positive effect on the company's profits.
Daniel Vasella, CEO of leading pharmaceutical group Novartis, told
shareholders that the company had experienced a good start to 2002
and that it expected profits to top last year's record.
Nutra Pharma of the US says it expects to see the first four wound
healing applications of its proprietary herbal extract compound
WD-667 hit the market in the next two months.
The US market for complementary & alternative medicine (CAM)
totalled $30 billion (€34bn) in 2001, according to a recent report
from Nutrition Business Journal. Significantly, CAM and mainstream
practitioners accounted for $1.24...
Advicor, the cholesterol control product from Kos Pharmaceuticals,
has been found to be highly effective in controlling the full range
of lipids when compared to two other leading statin products,
according to a new study presented...
Forbes Medi-Tech has said it will not exercise its right to buy
back the licensing and distribution rights to Reducol, the
cholesterol-lowering ingredient from Novartis.
Most Americans consume only half of the 25-35g recommended daily
allowance (RDA) of dietary fibre, according to recent statistics
from the American Diabetic Association. Benefiber, a new
easy-to-swallow product from Novartis Consumer...
Reliv International returned to profitability in 2001, despite a
decline in overall sales, as restructuring measures announced a
year earlier began to take effect.
Relora, a natural ingredient produced by Next Pharmaceuticals, has
been shown clinically to significantly alter the hormone levels
associated with stress-induced obesity, the company claims.
Pain Therapeutics, a US-based medical research company, is to
develop two new opioid painkillers, OxyTrex and MorViva, both of
which it claims do not lead to the tolerance and dependance
associated with other opioid painkillers.
